INTRODUCTION Pars plana vitrectomy as a technique has revolutionized retinal surgery since its advent and initial report by Machemer et al 1. It allowed the removal of traction by an internal method, essential in retinal detachment procedures, as well as provided an active management modality for vitreous haemorrhage and opened the door for surgical intervention in a myriad of retinal pathologies....Read More
Treatment
Lensopedia: Lenses in Ophthalmology
Introduction: While there are several instruments in ophthalmological practice, lenses form an inseparable part of an ophthalmologist’s arsenal. Available in various sizes and shapes, they are crucial in aiding the visualization of remote areas of the eye and facilitate therapeutic interventions in those areas which would be next to impossible to even imagine without their availability. Harnessing...Read More
LASERs in Ophthalmology: A Concise Guide for the Postgraduates
LASER is an acronym for “light amplification by stimulated emission of radiation”. Invented more than 50 years ago, today lasers are synonymous with precision and sophistication. The first medical application of lasers was the use in retinal photocoagulation and that role has been ever-evolving. Today its application is evident in all subspecialties of ophthalmology as a diagnostic and therapeutic...Read More
Polypoidal Choroidal Vasculopathy
Introduction Polypoidal Choroidal Vasculopathy (PCV), first described by Yannuzzi et al1 in 1982, is a distinct clinical entity characterized by persistent recurrent serous leakage and hemorrhage in the macula, and is seen in the elderly population. The disorder was poorly understood earlier and had been described by various authors as recurrent pigment epithelial detachment (PED) and posterior uv...Read More
Introduction History In 1908 George Coats1 original description of the disease was based primarily on histopathologic examination of enucleated eyes and identified retinal vascular aneurysms, arteriovenous malformations, intra- and subretinal hemorrhages, and exudates. Coats categorized eyes with these characteristic morphologic findings into three groups: Group I demonstrated massive subretinal e...Read More
How do we treat inflammatory CNVM ?
Inflammatory choroidal neovascular membranes (CNVM) cause an acute and significant visual loss 1,2. Mostly affecting eyes with posterior or panuveitis, the chronic recurrent nature of inflammation further worsens the visual prognosis in these eyes, such as serpiginous like choroiditis, punctuate inner choroidopathy (PIC), multifocal choroiditis, Vogt-Koyanagi-Harada (VKH) disease, presumed ocular ...Read More
1. Science behind Multifocal Intraocular Lens (MFIOL) Multifocal intraocular lenses are IOLs which can separate incoming light into two or more foci, thus resulting in multiple coexisting retinal images. At any given point, only one of the images (distance, intermediate or near) is the sharpest, and hence selected by the brain for visualisation. This concept is known as simultaneous vision. The vi...Read More
Management of Dropped Nucleus and Retained Lens Fragment
Introduction: Drooped nucleus and retained lens fragment is a complication not so rare in clinical practice. In the era where cataract surgery is being performed for visual enhancement rather than visual rehabilitation, the management of a dropped nucleus saves the patient from unnecessary anxiety and hastens visual recovery. In this chapter risk factors, the timing of surgery, various approaches ...Read More
Vascular endothelial growth factor (VEGF)-A is a key mediator of angiogenesis. The discovery of VEGF-A, like many other major discoveries in medicine, happened partly by observations and partly by chance. Napoleone Ferrara and his team were working on a population of non-hormone-secreting cells from the anterior pituitary of cows. (1) One day Ferrara mixed some isolates from cultures of follicular...Read More
Five Things You Should Know About Intracameral Bimatoprost Sustained Release Implant
The Implant Durysta (ALLERGAN) is the first-ever intracameral sustained-release bimatoprost implant. The glaucoma treatment paradigm has shifted towards earlier intervention and targeting the actual pathology. The main problem one faces with glaucoma management is compliance with the medications. The intracameral bimatoprost addresses the problem satisfactorily. Durysta, a 10-microgram bimatoprost...Read More